Results 131 to 140 of about 166,627 (157)

Evaluation of Cross-Immunogenicity of Ferret Antisera Following Immunization with H5N1 Vaccine Strains. [PDF]

Vaccines (Basel)
Kim S, Jang EY, Moon SY, Choi EB, Lee HW, Song MS, Kim BK, Lee Y, Ouh IO.   +8 more
europepmc   +1 more source

Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]

Vaccines (Basel)
Mokalla VR, Gundarapu S, Kaushik RS, Rajput M, Tummala H.   +4 more
europepmc   +1 more source

Innovative adjuvant strategies for next-generation pertussis vaccines. [PDF]

Hum Vaccin Immunother
Yu G, Yang W, Ma Y, Zhang N, Tang D, Jin Y, Shi L, Wang M, Liu D, Xue C, Sun B.   +10 more
europepmc   +1 more source

A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine. [PDF]

Front Immunol
Wang Z, Guo Y, Tang X, Sun Y, Wu T, Peng H, Wang C, Su W, Jiang C, Zang Y, Quan Y, Xu K, Sun B.   +12 more
europepmc   +1 more source

Cytomegalovirus Vaccines in Transplantation: History, Hurdles, and Hope. [PDF]

Transpl Infect Dis
Goodwin ML, Limaye AP, Heldman MR.
europepmc   +1 more source

Not just another shot: Tailoring vaccination in the era of modern liver transplantation. [PDF]

World J Transplant
Papic N, Kosuta I, Ljubas D, Vrsaljko N, Sesa V, Domislovic V, Ahsan S, Mrzljak A.   +7 more
europepmc   +1 more source

Mapping the monoclonal antibody landscape of human cytomegalovirus. [PDF]

J Virol
McClave MK, Heldwein EE.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice

Viral Immunology, 2023
Min Lv, Shuang Bai
exaly  

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection

Expert Review of Vaccines, 2007
Derek O'hagan
exaly  

MF59™ as a vaccine adjuvant: a review of safety and immunogenicity

Expert Review of Vaccines, 2010
Hana El Sahly
exaly